Bellevue | Küsnacht, 07.07.2016. MARKET REVIEW The Nasdaq Biotech Index (NBI) ended the month of June down -7.8% in USD. BB Biotech’s NAV was down -6.8% in USD, -8.3% in CHF and down -6.4% in EUR. BB Biotech’s share price was down -8.1% in USD, down -9.5% in CHF and -7.2% in EUR. After a short recovery in May, markets have been shaken again in June, following the unexpected “Brexit” vote from the UK. Investors were caught off-guard by the result of the EU referendum …
Lesen Sie mehr »Tagesarchiv
Pressemitteilung Bellevue Group: Annual General Meeting of Bellevue Group AG: Thomas von Planta elected new Chairman – Mirjam Staub-Bisang elected as new director – all resolutions approved
Bellevue | Küsnacht, 16.03.2015. Annual General Meeting of Bellevue Group AG on March 16, 2015. At the Annual General Meeting, the shareholders of Bellevue Group AG approved all proposals put forward by the Board of Directors. The Annual General Meeting elected Thomas von Planta, who had already served on the Board of Directors, Chairman as former Chairman Walter Knabenhans was not standing for re-election. Mirjam Staub-Bisang, founder and Chief Executive Officer of Independent Capital Group AG, was elected to the …
Lesen Sie mehr »